← All organizations

JenKem Technology Co., Ltd.

For profit

Also known as: JenKem Technology Co., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 26, 2024

Timeline

2000s

Oct 9, 2001
JenKem Technology Co., Ltd.— Founded

Drugs by trial phase (3 distinct, 5 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

temozolomide

Indications

Studied for

Neoplasms

Recent trials (7)

NCT06586866Lead sponsorPhase 2Sep 26, 2024
NCT06581380Lead sponsorPhase 3Sep 16, 2024
NCT06595186Lead sponsorPhase 2Oct 31, 2022
NCT05158491Study chairPhase 1/Phase 2Nov 11, 2021
NCT05158491Lead sponsorPhase 1/Phase 2Nov 11, 2021
NCT04366648Study chairPhase 1May 4, 2018
NCT04366648Lead sponsorPhase 1May 4, 2018

Details

Founded: Plano, Texas, US Oct 9, 2001
Last known activity: Sep 26, 2024